Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13.

[1]  M. Rowley,et al.  Antibodies to SOX13 (ICA12) are Associated with Type 1 Diabetes , 2001, Autoimmunity.

[2]  I. Mackay,et al.  Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi‐ethnic Australian community: the Fremantle Diabetes Study , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[3]  M. A. Kelly,et al.  Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population , 2000, Diabetologia.

[4]  M. Rowley,et al.  Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. , 2000, Diabetes.

[5]  B. Khalid,et al.  Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics. , 1999, Diabetes research and clinical practice.

[6]  G. Hitman,et al.  Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[7]  M. Rowley,et al.  Radioimmunoprecipitation Assay for Antibodies to Glutamic Acid Decarboxylase and Other Autoantigens in Microplates , 1998 .

[8]  P. Bingley,et al.  Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers , 1997, Diabetes.

[9]  A. Thai,et al.  Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM , 1997, Diabetologia.

[10]  M. Rowley,et al.  Evaluation of ICA512As in Combination With Other Islet Cell Autoantibodies at the Onset of IDDM , 1997, Diabetes Care.

[11]  G. Eisenbarth,et al.  Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM. , 1997, Diabetes research and clinical practice.

[12]  M. Rowley,et al.  Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus. , 1996, Journal of autoimmunity.

[13]  C. Rattarasarn,et al.  GAD Antibodies in IDDM in Thailand , 1996, Diabetes Care.

[14]  M. Rowley,et al.  Pancreatic β cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus , 1996 .

[15]  M. Rowley,et al.  Pancreatic Islet Cell Cytoplasmic Antibody in Diabetes is Represented by Antibodies to Islet Cell Antigen 512 and Glutamic Acid Decarboxylase , 1995, Diabetes.

[16]  S. Nagataki,et al.  Antibodies to GAD in Japanese diabetic patients: a multicenter study. , 1995, Diabetes research and clinical practice.

[17]  M. Rowley,et al.  Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. , 1995, Clinical immunology and immunopathology.

[18]  E. Bonifacio,et al.  Antibodies to Islet 37k Antigen, But Not to Glutamate Decarboxylase, Discriminate Rapid Progression to IDDM in Endocrine Autoimmunity , 1994, Diabetes.

[19]  H. Yamasaki,et al.  The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. , 1994, Journal of autoimmunity.

[20]  L. Harrison,et al.  Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. , 1994, Journal of autoimmunity.

[21]  M. Rowley,et al.  HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. , 1993, Human immunology.

[22]  M. Rowley,et al.  Antibodies to Glutamic Acid Decarboxylase Discriminate Major Types of Diabetes Mellitus , 1992, Diabetes.

[23]  D. U. Rabin,et al.  Cloning and Expression of IDDM-Specific Human Autoantigens , 1992, Diabetes.

[24]  J. Tuomilehto.  Geographic Patterns of Childhood Insulin-Dependent Diabetes Mellitus , 1988, Diabetes.